Cargando…

Ketamine: Various toxicities following off-label use of ketamine: 3 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160405/ http://dx.doi.org/10.1007/s40278-021-96572-3

Ejemplares similares

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Azithromycin/chloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Chloroquine/hydroxychloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Tocilizumab: Various toxicities following off label use: 4 case reports
Publicado: (2021)

Anakinra: Various toxicities following off label use: 7 case reports
Publicado: (2021)

Dexamethasone: Various toxicities and off-label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities and off label use: 3 case reports
Publicado: (2020)

Hydroxychloroquine: Various toxicities secondary to off label use: 3 case reports
Publicado: (2020)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Ketamine: Cholangitis: 3 case reports
Publicado: (2022)

Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2020)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities following off-label use and lack-of-efficacy: case report
Publicado: (2021)

Multiple drugs: Various toxicities, and lack of efficacy following off-label use: case report
Publicado: (2022)

Fluvoxamine/theophylline: Various toxicities following drug interaction and off-label use: case report
Publicado: (2022)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Azithromycin/chloroquine: Various toxicities following off-label treatment: 2 case reports
Publicado: (2021)

Lopinavir/ritonavir/ribavirin: Various toxicities following off-label treatment: case report
Publicado: (2020)

Multiple drugs: Various toxicities following interaction and off-label: 2 case reports
Publicado: (2020)

Multiple drugs: Various toxicities and off label use: 5 case reports
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: 10 case reports
Publicado: (2021)

Lopinavir/ritonavir: Various toxicities following off-label use in COVID-19: 4 case reports
Publicado: (2021)

Mania following ketamine abuse
por: Lu, Yuan-Yuan, et al.
Publicado: (2016)

Ketamine: Sclerosing cholangitis: case report
Publicado: (2021)

KETAMINE ABREACTION - TWO CASE REPORTS
por: Golechha, G.R., et al.
Publicado: (1985)

Ketamine abuse: Uropathy: case report
Publicado: (2022)

The Case of Ketamine Allergy
por: Bylund, William, et al.
Publicado: (2017)

Multiple drugs: Various toxicities, lack-of-efficacy and off-label use: case report
Publicado: (2021)

Baricitinib/hydroxychloroquine: Various toxicities secondary to off-label use: 4 case reports
Publicado: (2021)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Multiple drugs: Various toxicities, lack of efficacy following off label use and vaccine failure: case report
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and lack of efficacy: case report
Publicado: (2020)

Multiple drugs: Various toxicities, off-label use and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: Various toxicities with lack of efficacy and off label use: case report
Publicado: (2022)

Ketamine and Pulmonary Oedema–Report of Two Cases
por: Parthasarathy, S, et al.
Publicado: (2009)

Various drugs: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Deferasirox/hydroxychloroquine: Various toxicities and off-label use in coronavirus disease 2019: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy, and various toxicities due to off-label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rlisqi25k1m79j63jis4ifdhua